Physician profile
Deborah Holubec
NPI 1831169077
$1,160.70
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $194 · 2020: $287 · 2021: $239 · 2022: $181 · 2023: $180 · 2024: $79.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $259.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $409.24 | 2019-2022 | |
| Medtronic USA, INC. | $125.56 | 2020 | |
| Azurity Pharmaceuticals, INC. | $89.31 | 2023-2024 | Horizant, Horizant |
| Biohaven Pharmaceutical Holding Company LTD. | $73.82 | 2022 | |
| Assertio Therapeutics, INC. | $60.02 | 2019-2020 | |
| Abbvie INC. | $57.75 | 2021-2023 | |
| Idorsia Pharmaceuticals US INC | $52.63 | 2023-2024 | Quviviq |
| Averitas Pharma INC. | $48.01 | 2023 | Qutenza |
| Boston Scientific Corporation | $45.58 | 2019-2023 | |
| Medtronic, INC. | $33.77 | 2021 | |
| Redhill Biopharma INC. | $23.18 | 2020 | |
| Trevena, INC. | $22.13 | 2023 | Olinvyk |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.19 | 2019 | |
| Abbott Laboratories | $16.45 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $16.43 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $15.26 | 2022 | |
| Sentynl Therapeutics, INC. | $14.17 | 2019 | |
| Fidia Pharma USA INC. | $14.16 | 2023 | Hymovis, Triluron |
| Avanos Medical | $12.69 | 2021 | |
| Ibsa Pharma INC. | $12.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Holubec listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.